HIGHLIGHTS
- who: Kostas Palamaris and collaborators from the First Department of Pathology, National and Kapodistrian University of Athens, Athens, Greece have published the Article: Histone Deacetylases (HDACs): Promising Biomarkers and Potential Therapeutic Targets in Thymic Epithelial Tumors, in the Journal: (JOURNAL)
- what: The authors attempt the first comprehensive evaluation of six class I (HDAC1 and II HDACs (HDAC4 expression patterns in tumors (TETs) with the aim of identifying their possible association with a number of clinicopathological parameters. Considering the lack of systematic analyses of the HDAC expression profile in TETs, along with the fact that HDACs . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.